Physician
Jefferson-Byrd, Brenda
Jefferson-Byrd, Brenda was paid $1.06M by Medicaid between Nov 2019 and Dec 2024, across 22 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 39% of everything it billed.
33Billing provider infoJEFFERSON-BYRD, BRENDA
AURORA, IL 60504
AURORA, IL 60504
33aNPI1285717595assigned 10/23/2006
33bProvider typeFamily Medicine Physician
28Total paid$1.06M
24GClaims26,911
24DCodes billed22
24AFirst – last monthNov 2019 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Illinois
Rank by total paid#91 of 2,947
Median peer was paid$43K
This provider vs. median25×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 35 | $2K | |
| 2020 | 111 | $2K | |
| 2021 | 1,731 | $79K | |
| 2022 | 5,186 | $208K | |
| 2023 | 8,640 | $298K | |
| 2024incomplete | 11,208 | $468K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 39% | 5,601 | 4,430 | $414K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 3,371 | 2,784 | $164K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 12% | 3,727 | 3,198 | $125K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 8.7% | 1,854 | 1,648 | $92K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 8.6% | 1,124 | 1,002 | $91K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5.3% | 2,925 | 1,882 | $56K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3.4% | 1,524 | 1,394 | $35K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.1% | 2,198 | 1,833 | $32K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.0% | 147 | 146 | $11K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.0% | 943 | 669 | $11K |
| 87807 | <1% | 729 | 616 | $7K | |
| 99384 | <1% | 54 | 54 | $5K |
10 more codes
| 99383 | <1% | 52 | $4K | |
| 81002 | <1% | 1,537 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 183 | $2K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 93 | $2K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 26 | $1K |
| 81025 | <1% | 253 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 279 | $199.59 |
| 99173 | <1% | 13 | $67.86 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 75 | $67.17 |
| 36415 | Collection of venous blood by venipuncture | <1% | 203 | $1.92 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.